ALEMBIC PHARMACEUTICALS LTD.
Market Cap.(`)
|
16262.65 Cr.
|
P/BV
|
3.33
|
Book Value (`)
|
248.68
|
52 Week High/Low ( ` )
|
1304/725
|
FV/ML
|
2/1
|
P/E(X)
|
26.41
|
Book Closure
|
15/07/2024
|
EPS (`)
|
31.33
|
Div Yield (%)
|
1.33
|
(` in Crs.)
You can view the
Consolidated
Cash Flow
for the last 5 years.
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | |
Net Profit/Loss Before Extraordinary Items And Tax | 631.83 | 354.59 | 620.11 | 1368.08 | 999.82 |
| | | | | |
Net CashFlow From Operating Activities | 803.20 | 723.95 | 552.36 | 1463.38 | 449.13 |
Net Cash Used In Investing Activities | -320.61 | -447.59 | -371.97 | -838.81 | -731.63 |
Net Cash Used From Financing Activities | -437.86 | -261.96 | -217.36 | -597.42 | 154.86 |
Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | -0.93 | 0.41 |
| | | | | |
Net Inc/Dec In Cash And Cash Equivalents | 44.73 | 14.40 | -36.97 | 26.22 | -127.23 |
Cash And Cash Equivalents Begin of Year | 75.48 | 61.08 | 98.06 | 71.84 | 199.07 |
Cash And Cash Equivalents End Of Year | 120.21 | 75.48 | 61.09 | 98.06 | 71.84 |